Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study

Roland Stocker; Christine Pollicino; Craig A Gay; Paul J Nestel; David Colquhoun; Malcolm Whiting; Andrew Maxwell Tonkin; David Sullivan; John Simes

doi:10.1016/j.atherosclerosis.2005.09.004

Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study

Roland Stocker, Christine Pollicino, Craig A Gay, Paul J Nestel, David Colquhoun, Malcolm Whiting, Andrew Maxwell Tonkin, David Sullivan, John Simes

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	198 - 204
Number of pages	7
Journal	Atherosclerosis
Volume	187
Issue number	1
DOIs	https://doi.org/10.1016/j.atherosclerosis.2005.09.004
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.atherosclerosis.2005.09.004

Cite this

Stocker, R., Pollicino, C., Gay, C. A., Nestel, P. J., Colquhoun, D., Whiting, M., Tonkin, A. M., Sullivan, D., & Simes, J. (2006). Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study. Atherosclerosis, 187(1), 198 - 204. https://doi.org/10.1016/j.atherosclerosis.2005.09.004

@article{4ab5d873f97d4884b52fbabd9f0b9de0,

title = "Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study",

author = "Roland Stocker and Christine Pollicino and Gay, {Craig A} and Nestel, {Paul J} and David Colquhoun and Malcolm Whiting and Tonkin, {Andrew Maxwell} and David Sullivan and John Simes",

year = "2006",

doi = "10.1016/j.atherosclerosis.2005.09.004",

language = "English",

volume = "187",

pages = "198 -- 204",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier",

number = "1",

}

Stocker, R, Pollicino, C, Gay, CA, Nestel, PJ, Colquhoun, D, Whiting, M, Tonkin, AM, Sullivan, D & Simes, J 2006, 'Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study', Atherosclerosis, vol. 187, no. 1, pp. 198 - 204. https://doi.org/10.1016/j.atherosclerosis.2005.09.004

Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study. / Stocker, Roland; Pollicino, Christine; Gay, Craig A et al.
In: Atherosclerosis, Vol. 187, No. 1, 2006, p. 198 - 204.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study

AU - Stocker, Roland

AU - Pollicino, Christine

AU - Gay, Craig A

AU - Nestel, Paul J

AU - Colquhoun, David

AU - Whiting, Malcolm

AU - Tonkin, Andrew Maxwell

AU - Sullivan, David

AU - Simes, John

PY - 2006

Y1 - 2006

U2 - 10.1016/j.atherosclerosis.2005.09.004

DO - 10.1016/j.atherosclerosis.2005.09.004

M3 - Article

SN - 0021-9150

VL - 187

SP - 198

EP - 204

JO - Atherosclerosis

JF - Atherosclerosis

IS - 1

ER -